While fee-for-service models incentivize in-clinic treatments, value-based care shifts the focus to outcomes and overall cost. Under these new models, home dialysis—which offers better patient outcomes and lower societal costs—becomes more profitable for providers, creating a powerful financial incentive to drive adoption.

While SmallTap's higher clinical success rate is key, its adoption is driven by benefits to multiple stakeholders. The messaging highlights reduced physical strain on nurses, lower stress for doctors, and a clear financial ROI for hospitals by avoiding unnecessary admittances.

Administering complex biologics at home via on-body devices can bridge significant healthcare disparities. This model can eliminate the physical, financial, and geographic barriers faced by patients in rural areas or those reliant on caregivers for transport to infusion centers.

A landmark study by Roger Ulrich found that post-surgery patients in rooms with a view of trees recovered about a day faster and required less pain medication than patients whose rooms faced a brick wall. This provides strong evidence that even a passive view of nature can have significant, measurable effects on physical healing.

The 'Home Away From Home' program offers free housing to families who must travel for a child's cancer treatment. This seemingly non-medical support directly tackles treatment abandonment, making it one of the most effective interventions for improving survival rates in low-income regions.

The economic case for a prophylactic drug isn't just clinical. Its real value is enabling expensive, multi-week inpatient procedures (like CAR-T side effect observation) to become outpatient treatments, freeing up hospital beds and massively reducing healthcare system costs.

The "Hospital at Home" model is evolving beyond just discharging patients early. Healthcare systems can now admit patients directly to their own homes for acute conditions like pneumonia or skin infections, bypassing the traditional hospital stay entirely. This represents a fundamental shift in how acute care is delivered, moving from a centralized facility to a distributed, home-based model.

The key challenge in implementing "Hospital at Home" is not the medical technology, which is mature, but rather coordinating a complex supply chain. Success requires an "Uber-like" system for on-demand delivery of pharmacy, labs, radiology, and specialists. This makes it more of a logistical and cultural problem than a purely technological one.

The popularity of at-home diagnostics and health protocols isn't just about clinical outcomes. It fulfills a deep-seated human need for control over one's health, a feeling the traditional 'wait and see' medical system often denies patients.